Ortho-McNeil Articles

Bayer/Ortho-McNeil’s VTE drug Xarelto will earn peak-year sales of $500 million to $1 billion

17 May 2011

Johnson & Johnson subsids to pay $81.5 million over off-label promo of Topamax, and Solvay unit agrees $22 million settlement on Deponit and Hyoscyamine

30 April 2010

Showing 1-2 of 2 articles

Go to beginning

Previous

1

Next

Go to end